Positron Corp (POSC) 0.0482 $POSC Positron Anno
Post# of 273249
Posted On: 06/19/2016 6:07:01 PM
Positron Corp (POSC) 0.0482 $POSC
Positron Announces Terms Of Its Financial Restructuring
PR Newswire - Tue May 10, 4:38PM CDT
Positron Corporation (OTC Markets: POSCE) (the "Company"
, a nuclear medicine healthcare company, announced today that the Company entered into a settlement agreement for structured dismissal. If confirmed, the settlement will allow the Company to avoid entering a bankruptcy proceeding.
Japan Nuclear Imaging Equipment Market Trend, Strategy and Research Report 2020: Radiant Insights, Inc
M2 - Wed Apr 08, 4:29AM CDT
GlobalData's new report, "Japan Nuclear Imaging Equipment Market Outlook to 2020", provides key market data on the Japan Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Positron Emission Tomography Systems (PET Systems and PET/CT Systems) and Single Photon Emission Computed Tomography Systems (SPECT Systems and SPECT/CT Systems).
Positron Announces Reverse Split of Common Stock
PR Newswire - Tue Apr 07, 9:26AM CDT
Positron Corporation (OTCBB
OSC), a nuclear medicine healthcare company ("Positron" or the "Company" , today announced the approval of its reverse stock split of Positron common stock on a 1-for-400 basis. The Company anticipates the split will be effective on April 8, 2015. At the opening of trading on that day, Positron's common stock will begin trading on a 1:400 reverse split-adjusted basis.
Intra-Cellular Therapies Presents the ITI-007 Clinical Development Program at the 15th International Congress on Schizophrenia Research
GlobeNewswire - Tue Mar 31, 7:00AM CDT
Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, presented data regarding the ITI-007 development program and described the rationale supporting the strategy for the advancement of ITI-007 in multiple clinical indications at the 15th International Congress on Schizophrenia Research (ICOSR) in Colorado Springs.
ITCI: 37.43 (-1.78)
MediPoint: Nuclear Imaging - EU Analysis and Market Forecasts
PR Newswire - Mon Mar 23, 3:16PM CDT
Summary
MediPoint: Nuclear Imaging - South America Analysis and Market Forecasts
PR Newswire - Mon Mar 23, 3:06PM CDT
Summary
MediPoint: Nuclear Imaging - APAC Analysis and Market Forecasts
PR Newswire - Mon Mar 23, 2:50PM CDT
Summary
Leading 100 medical technology companies of USA/Canada 2015
M2 - Mon Mar 23, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7pc3fm/usacanada) has announced the addition of the "USA/Canada Medical Technology 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Health care technology assessment is a thriving industry in the United States, used by government, insurers, medical societies, hospitals, and other groups for their own purposes. Most of the top medical technology companies come from the United States. In general, trends show an increasing use of medical technology products with demand expected to grow some four percent in the United States. In Canada too, the medical device advancements help save the lives of patients by improving the accuracy of diagnoses, enhancing treatments and cure of diseases, reducing long-term disabilities and helping to provide better medical care. Covering a wide range of products, medical technology examples include pacemakers, artificial heart valves, hip implants, synthetic skin, scalpels, and medical laboratory diagnostic instruments. With this special industry report, our endeavor is to provide the new investors with a complete resourceful research report for familiarizing with the present investment trends in the USA/Canadian medical technology industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical technology companies of USA/Canada - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances with foreign companies - International presence of USA/Canadian medical technology companies - R&D activities in the industry Report Includes Companies Engaged in: - Manufacturing research instruments and scientific analytical equipment - Providing software for improving treatments - Providing medical information technology - Manufacturing medical bio-tech products - Providing value-based healthcare services - Manufacturing molecular diagnostic instruments - Manufacturing pacemakers, imaging instruments, dialysis machines and implants, hip and knee replacement medical devices, heart stents, thermal cyclers and mass spectrometers, microarrays and other similar products Key Topics Covered: Introduction Analysis Section 1. Rankings of Medical Technology Companies of USA/Canada 1.1. Leading 100 Medical Technology Companies of USA/Canada (based on recent sales, net income, total assets, total equity) 1.2. Most Growing 25 Medical Technology Companies of USA/Canada 1.3. Most Profitable 25 Medical Technology Companies of USA/Canada 2. Stock Market Performance over 5 Years. Leading 25 Medical Technology Companies of USA/Canada News Section 3. Key News of Medical Technology Sector in USA/Canada for Year 2014 3.1 - Key Company News. By Country and Company 3.2 - Key Company News. By News Category 3.3 - Key Industry News. By News Category 4. International Alliances of Medical Technology Companies in USA/Canada 5. International Presence of USA/Canadian Medical Technology Companies 6. Research and Development Activities in USA/Canadian Medical Technology Industry 7. Mergers and Acquisitions in USA/Canadian Medical Technology Industry Companies Mentioned (Partial List) - LED Medical Diagnostics Incorporated (Canada) - Masimo Corporation (United States) - Mazor Robotics Ltd (United States) - Medtronic, Incorporated (United States) - Mela Sciences Incorporation (United States) - Novation Holdings, Inc. (United States) - Oncologix Tech, Inc. (United States) - Pathfinder Cell Therapy Inc (United States) - Positron Corporation (United States) - Revolutions Medical Corporation (United States) - Rockwell Medical Incorporated (United States) - SQI Diagnostics Inc. (Canada) - The Cooper Companies, Inc. (United States) - Titan Medical Inc. (Canada) For more information visit http://www.researchandmarkets.com/research/7pc3fm/usacanada
MASI: 50.50 (-1.02), MDT: 84.14 (-0.45), MZOR: 16.03 (+0.17)
Research and Markets: MediPoint: Nuclear Imaging - APAC Analysis and Market Forecasts to 2020
BusinessWire - Mon Mar 23, 7:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mxck48/medipoint) has announced the addition of the "MediPoint: Nuclear Imaging - APAC Analysis and Market Forecasts" report to their offering.
MediPoint: Nuclear Imaging - APAC Analysis and Market Forecasts to 2020
M2 - Mon Mar 23, 6:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cf2bnd/medipoint) has announced the addition of the "MediPoint: Nuclear Imaging - APAC Analysis and Market Forecasts" report to their offering. This report examines how new technologies can emerge in the face of economic pressures that may affect the demand for nuclear imaging, and how healthcare reforms are impacting nuclear medicine. The advent of hybrid imaging has enabled PET/CT imaging to undergo explosive growth. However, this has been at the cost of an increased demand on struggling healthcare budgets. PET and SPECT imaging are well established techniques within nuclear imaging, and are the main focus of this report PET imaging uses Positron Emitting radioactive tracers with a short half life, to image metabolically active organs PET combined with CT allows precise anatomical imaging of the body, identifying diseased areas depending upon the tracer used PET/CT is most often used for cancer diagnosis PET/MRI is a new technique that was introduced to reduce patient exposure to radiation PET only systems are now generally considered obsolete, due to the superior imaging quality of PET/CT Scope - An overview of Nuclear Imaging, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized APAC Nuclear Imaging market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Nuclear Imaging - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Nuclear Imaging sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers and Barriers 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlooks 12 Appendix Companies Mentioned - DDD-Diagnostic - Digirad - GE Healthcare - GVI Medical Devices - Mediso Medical Imaging Systems - NeuroLogica - Neusoft Medical Systems - NuCare Medical Systems - Oncovision - Philips Healthcare - Shimadzu - Siemens Healthcare - SurgicEye - Toshiba Medical For more information visit http://www.researchandmarkets.com/research/cf2bnd/medipoint
MDSY: 1.50 (-0.01)
MediPoint: Nuclear Imaging - EU Analysis and Market Forecasts 2014-2020
M2 - Mon Mar 23, 6:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2n27tb/medipoint) has announced the addition of the "MediPoint: Nuclear Imaging - EU Analysis and Market Forecasts" report to their offering. This report examines how new technologies can emerge in the face of economic pressures that may affect the demand for nuclear imaging, and how healthcare reforms are impacting nuclear medicine. The advent of hybrid imaging has enabled PET/CT imaging to undergo explosive growth. However, this has been at the cost of an increased demand on struggling healthcare budgets. PET and SPECT imaging are well established techniques within nuclear imaging, and are the main focus of this report PET imaging uses Positron Emitting radioactive tracers with a short half life, to image metabolically active organs PET combined with CT allows precise anatomical imaging of the body, identifying diseased areas depending upon the tracer used PET/CT is most often used for cancer diagnosis PET/MRI is a new technique that was introduced to reduce patient exposure to radiation PET only systems are now generally considered obsolete, due to the superior imaging quality of PET/CT An early diagnosis of disease is the foundation of increasing survival rates. Single-photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging are diagnostic imaging techniques that are widely used in a variety of disease areas including oncology, cardiovascular disease, bone disease, and infectious disease. This report provides an analysis of the nuclear imaging market, with a particular focus on SPECT and PET imaging and hybrid modalities within the 5EU (France, Germany, Italy, Spain, and UK). Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 3.1 Nuclear Imaging Techniques 3.2 Clinical Applications of Nuclear Imaging Technology 3.3 Advantages and Disadvantages of Nuclear Imaging Technologies 3.4 Market Access 3.5 Reimbursement 3.6 Procedure Trends 3.7 Regulatory Issues/Recalls 3.8 M&As and Key Partnerships 3.9 Economic Impact 4 Unmet Needs 4.1 Overview 4.2 Improved Reimbursement for New Techniques 4.3 Lack of Binding Clinical Guidelines 4.4 Patient Comfort and Convenience 4.5 Reducing Radiation Exposure 4.6 Improved Scanner Performance 4.7 Image Processing Software Improvements 4.8 Increased Risk of Artifacts in Hybrid Images 4.9 Demand for New Radiotracers 4.10 Improved Clinical Input into the Design Process 5 Market Opportunity Analysis 5.1 Cheaper, Simpler Nuclear Imaging Devices 5.2 SPECT/CT in Developing Countries 5.3 Increased Demand for Teleradiology Services 6 Market Drivers and Barriers 7 Competitive Assessment 7.1 Overview 7.2 Dedicated PET Systems 7.3 PET/CT Systems 7.4 PET/MRI Systems 7.5 Dedicated SPECT Systems 7.6 SPECT/CT Systems 7.7 PET/Ultrasound and SPECT/Ultrasound Systems 8 Pipeline Assessment 8.1 Overview 8.2 Pipeline by Phases in Development 8.3 Product Profiles 8.3.1 Brain Biosciences CerePET 8.3.2 ECORAD Dual Modality Imager 8.3.3 FMI Technologies ScintiStar PET/CT 8.3.4 IntraMedical Imaging Marginator Beta Camera 8.3.5 INSERT SPECT/MRI 8.3.6 Nucare/Zecotek Photonics New Generation PET Scanning Device 8.3.7 Philips Healthcare PET Alpha Ring Detector 8.3.8 Photo Diagnostic Systems NeuroPET/CT 8.3.9 SynchroPET Breast PET/MRI 8.3.10 SynchroPET Wrist Scanner 8.3.11 SurgicEye SPECT Hybrid 9 Clinical Trials to Watch 10 Current and Future Players 10.1 Overview 10.2 Trends in Corporate Strategy 10.3 Company Profiles 10.3.1 DDD-Diagnostic 10.3.2 Digirad 10.3.3 GE Healthcare 10.3.4 GVI Medical Devices 10.3.5 Mediso Medical Imaging Systems 10.3.6 NeuroLogica 10.3.7 Neusoft Medical Systems 10.3.8 NuCare Medical Systems 10.3.9 Oncovision 10.3.10 Philips Healthcare 10.3.11 Shimadzu 10.3.12 Siemens Healthcare 10.3.13 SurgicEye 10.3.14 Toshiba Medical 10.3.15 Other Companies 11 Market Outlooks 12 Appendix For more information visit http://www.researchandmarkets.com/research/2n27tb/medipoint
MDSY: 1.50 (-0.01)
Positron Access Names Alan Pritchard Senior Vice President of Sales
PRWeb - Thu Feb 19, 5:07AM CST
Positron Access Solutions, the leader in high bandwidth Ethernet over copper pairs solutions, is pleased to announce the appointment of Alan Pritchard as Senior Vice President of Sales. Pritchard, a veteran in the telecom industry, will lead the sales growth of Positron's FlexStream bonded-copper and fiber solutions, which deliver 100 Mbps to Gigabit Ethernet services over copper and fiber infrastructure. Pritchard brings with him a wealth of experience and accomplishments in Carrier sales and business development. Previously he was VP of Sales at Coriant/Tellabs, SVP Business Development at Amerlink, and obtained extensive experience at Nortel including Global VP of Carrier Solutions.
Global Preclinical Imaging Market 2015-2019 with Aspect Imaging, Bioscan, Bruker, Mediso Medical Imaging Systems, PerkinElmer, Siemens Healthcare & Thermo Fisher Scientific Dominating
M2 - Sat Jan 31, 12:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/m5vndn/global) has announced the addition of the "Global Preclinical Imaging Market 2015-2019" report to their offering. The Global Pre-clinical Imaging market to grow at a CAGR of 15.02% over the period 2014-2019. Pre-clinical Imaging is in vivo imaging of small animals, which had been progressively deployed in drug development process. It helps in the visualizing and monitoring of animals for research with respect to tissue, organ, cell (at molecular level), and physiological and environmental changes. One of the main application areas of pre-clinical imaging is early detection of diseases. Currently the most used imaging modalities are optical (fluorescence and bioluminescence), PET, and MRI. In addition, multi-modalities such as PET CT and SPECT CT are the most used imaging combinations. In vivo imaging is increasingly used in target identification, compound optimisation and pre-Phase I studies, and in the drug development process. Thus, it bridges the gap between in vitro exploratory and in vivo clinical research. The use of multi-modalities imaging systems is a major trend in the market. Also, innovation and advances in technologies to meet research needs, safety, efficacy, and potential reversibility have resulted in the involvement of multi-modalities imaging systems. According to the report, an increase in R&D in pharma companies is one of the major drivers of the market. Because of the intense competition in the market, vendors try to develop new drugs and spend huge amounts toward drug development. Further, the report states that high cost is a major challenge that the market faces. The cost required to complete preclinical studies depends on the research involved. Vendors spend huge amounts on R&D, which will have a significant effect on the company's economy. Pre-clinical imaging systems can be segmented based on the type of equipment, as mentioned below: - Micro MRI - Micro-PET - Micro-CT - PAT - SPECT - Multi-modality - Optical Imaging - Ultrasound Key Vendors - Aspect Imaging - Bioscan (Subsidiary of Trifoil Imaging) - Bruker Corporation - Mediso Medical Imaging Systems - PerkinElmer - Siemens Healthcare - Thermo Fisher Scientific Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Type of Modality - Global Single Modality Imaging Technique Market - Global Multi-modality Imaging Technique Market - Market Segmentation by Sub-classification - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis Companies Mentioned - Aspect Imaging - Bioscan (Subsidiary of Trifoil Imaging) - Bruker Corporation - Mediso Medical Imaging Systems - PerkinElmer - Siemens Healthcare - Thermo Fisher Scientific - Agilent Technologies - Capintec - Hitachi Medical - LI-COR Biosciences - Miltenyi Biotec GMBH - Naviscan - Positron - Promega - Quintiles For more information visit http://www.researchandmarkets.com/research/m5vndn/global
A: 45.36 (-0.01), PKI: 52.35 (-0.38)
Institute for Nuclear Research of the Russian Academy of Sciences Granted U.S. Patent for Radiostrontium Production Technology Included in Licensing Agreement with Positron Corporation
PR Newswire - Tue Jan 20, 10:04AM CST
Positron Corporation (OTCBB: POSC) is pleased to announce that the United States Patent and Trademark Office (USPTO) has awarded the Institute for Nuclear Research (INR) of the Russian Academy of Sciences a patent (U.S. No. 8,929,503) for the method for producing strontium-82 (Sr-82) - a precursor to rubidium-82 (Rb-82), the leading radiopharmaceutical used in Positron Emission Tomography (PET) myocardial perfusion imaging. It is the second patent for this technology in North America included in a license agreement between INR and Positron Corporation: INR has been awarded a Canadian patent (CA 2719347) for the same technology in July 2014. The rights to this patented technology have been granted by INR to Positron Corporation. Although other licensees, from France and Russia, can sell Sr-82 produced with the patented technology, only Positron Corporation has the right to utilize the technology in North America.
Breast Imaging Technologies Market (Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound) will reach $3 Billion by 2019
M2 - Mon Dec 29, 6:01AM CST
This report studies the global Breast Imaging Technologies Market over the forecast period from 2014 to 2019. The market is expected to reach ~$3 billion by 2019, at CAGR of 8.1% from 2014 to 2019.
Breast Imaging Technologies Market will reach $3 Billion by 2019
M2 - Fri Nov 28, 5:52AM CST
The report "Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019" analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Global ESL Market 2015-2019: Key Vendors are Altiere, Displaydata, Pricer, Store Electronic Systems and Teraoka Seiko
M2 - Tue Nov 25, 4:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/9k2slf/global_esl_market) has announced the addition of the "Global ESL Market 2015-2019" report to their offering. Increased inclinations towards dynamic pricing are one of the emerging trends in this market. Retailers use various price optimization and revenue management techniques to exceed sales and increase profits. They use dynamic pricing and change product prices based on certain marketing strategies and market demand for products. According to the report, one of the major driving forces behind the success of ESLs is the return on investment they offer to retailers. It is estimated that retailers will get their full return on the investment they make on ESLs within 18 to 24 months from the implementation of these labels. Further, the report states that ESL vendors are witnessing a decline in their profit margins owing to the rise in prices of raw materials and increased competition among vendors. The new vendors are focused more on end-user requirements and are developing ESL solutions based on these requirements, which makes them a preferred choice for global vendors. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Global ESL Market Penetration 08. Market Segmentation by Retail Store Type 09. Market Segmentation by Wireless Solution 10. Market Segmentation by Distribution Channel 11. Geographical Segmentation 12. Impact of New Technologies in Retail 13. Buying Criteria 14. Market Growth Drivers 15. Drivers and their Impact 16. Market Challenges 17. Impact of Drivers and Challenges 18. Market Trends 19. Trends and their Impact 20. Vendor Landscape 21. Key Vendor Analysis 22. Other Reports in this Series Companies Mentioned: - Advantech US - Altiere - CEST - Displaydata - E Ink - ELTRADE - Herbert Retail - ILID - LG Innotek - Mirador Marketing - NZ Electronic Shelf Labelling - Opticon - Positron - PriceWizard - Pricer - Samsung ElectroMechanics - Store Electronic Systems - Tagnetics - Teraoka Seiko - Toshiba Global Commerce Solutions - UNO ESL - Wincor Nixdorf - Wuxi Wei Feng Technology - imagotag For more information visit http://www.researchandmarkets.com/research/9k...esl_market
Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging...) - Global Forecasts to 2019
PR Newswire - Wed Oct 29, 4:00PM CDT
The global breast imaging technologies market is estimated to grow at a CAGR of 8.1% from 2014 to 2019. Although the mature markets (such as the U.S., Germany, and the U.K.) hold larger shares in the breast imaging technologies market, the Asia-Pacific region is expected to grow at the highest CAGR of 10.2% in the forecast period. The growth of the breast imaging technologies market is driven by factors such as public and private initiatives to increase awareness about early breast cancer screening, technological developments, growing demand for the use of minimal or negligible doses of radiation, and increasingly aging population. However, factors such as side effects of radiation exposure and high installation cost of breast imaging systems are restraining the growth of this market. Moreover, emerging economies such as India and China are creating growth opportunities for the breast imaging technologies market in these regions.
SOFIE BIOSCIENCES receives $1.5M NCI Phase II SBIR
PR Newswire - Thu Oct 16, 8:03AM CDT
SOFIE BIOSCIENCES, a leader in the field of Positron Emission Tomography (PET) imaging, including probes, scanners, and chemistry systems, announced today that the National Cancer Institute (NCI) has awarded the company a Phase II Small Business Innovation Research (SBIR) contract for approximately $1.5M over two years. This contract will support the further development of SOFIE's family of proprietary imaging probes, known as [18F]FAC, that measure the enzyme, dCK, which controls the rate of DNA production through the salvage pathway. Cancer drugs, like gemcitabine and others, use dCK to convert the drug into a pharmacologically active product that blocks the high rates of DNA replication for growth of malignant cells. One of SOFIE's objectives with [18F]FAC is to use PET imaging to allow physicians to search throughout the body for tumors that will respond to drugs that target dCK, thus enabling more patient-specific treatment selection.
Global Breast Imaging Technologies Market to 2019
M2 - Thu Oct 16, 3:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jns6bn/breast_imaging) has announced the addition of the "Breast Imaging Technologies Market - Global Forecasts to 2019" report to their offering. The global breast imaging market holds a significant share of the medical device industry owing to rising awareness about the early screening of breast cancer. Though digital Mammography is the gold standard in the current breast imaging market, modalities such as breast MRI Scans, breast ultrasound and CTs are expected to drastically improve the breast Imaging Market scenario. This research analysis provides, a detailed information on breast imaging technological advancements in breast cancer diagnosis. This research report identifies and evaluates key advancements of breast screening modalities in development and approval stages. Patent analysis, investor analysis and investment opportunity evaluation along with multi-level criteria technology benchmarking are assessed within the breast imaging sector. Strategic recommendations for technology stakeholders are elaborately discussed in this research service. The global breast imaging market is estimated to grow at a CAGR of 8.1% in the forecast period. Global rise in the incidences and prevalence of breast cancer cases, rapid growth in aging population, development of advanced breast imaging technologies, and increasing awareness about early breast cancer screening are some of the key factors that are fueling the growth of the market. However, side effects of radiation dosage during breast imaging procedures, high installation cost of this systems, and false cancer diagnosis are some of the key factors hampering the growth of this market. Furthermore, stringent regulatory approvals for new technologies and government pressure to reduce the usage of radiation dose are some of the key challenges faced by market players. The emerging markets including China and India have become attractive for companies engaged in the development and marketing of the breast imaging technologies. Rising breast cancer awareness, government initiatives to increasing awareness about women healthcare, rising incidences of breast cancer, and increasing government investments in this technologies are the key factors propelling the demand of the this technologies in the emerging markets. In 2013, Hologic, Inc. (U.S.) held the leading position in the global mammography market. Over the past three years, the company adopted expansion of its R&D capabilities, new product launches, and strategic partnerships/agreements as its key business strategies to ensure its dominant position in this market. In addition, GE Healthcare (U.K.), Philips Healthcare (Netherlands), Siemens Healthcare (Germany), SonoCine, Inc. (U.S.), and Toshiba Corporation (Japan) are some other key players in the global mammography market. Scope of the Report By Type - Ionizing Breast Imaging Technologies - Analog Mammography - Full-Field Digital Mammography - 3D Breast Tomosynthesis - Positron Emission Tomography/Computed Tomography (PET/CT) - Molecular Breast Imaging (MBI) - Cone Beam Computed Tomography (CBCT) - Positron Emission Mammography (PEM) - Non-ionizing Breast Imaging Technologies - Breast MRI - Breast Ultrasound - Optical Imaging - Whole Breast Ultrasound - Breast Thermography Companies Mentioned - Aurora Imaging Technology, Inc. - Dilon Technologies, Inc. - Dune Medical Devices - Gamma Medica, Inc. - Ge Healthcare (Apart of General Electric Company) - Hologic, Inc. - Philips Healthcare (A Part of Konninklijke Philips N.V.) - Siemens Healthcare (A Part of Siemens AG) - Sonocine, Inc. - Toshiba Corporation For more information visit http://www.researchandmarkets.com/research/jn...st_imaging
GE: 30.60 (-0.04), HOLX: 33.81 (+0.11)
Positron Announces Terms Of Its Financial Restructuring
PR Newswire - Tue May 10, 4:38PM CDT
Positron Corporation (OTC Markets: POSCE) (the "Company"
, a nuclear medicine healthcare company, announced today that the Company entered into a settlement agreement for structured dismissal. If confirmed, the settlement will allow the Company to avoid entering a bankruptcy proceeding. Japan Nuclear Imaging Equipment Market Trend, Strategy and Research Report 2020: Radiant Insights, Inc
M2 - Wed Apr 08, 4:29AM CDT
GlobalData's new report, "Japan Nuclear Imaging Equipment Market Outlook to 2020", provides key market data on the Japan Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Positron Emission Tomography Systems (PET Systems and PET/CT Systems) and Single Photon Emission Computed Tomography Systems (SPECT Systems and SPECT/CT Systems).
Positron Announces Reverse Split of Common Stock
PR Newswire - Tue Apr 07, 9:26AM CDT
Positron Corporation (OTCBB
OSC), a nuclear medicine healthcare company ("Positron" or the "Company" , today announced the approval of its reverse stock split of Positron common stock on a 1-for-400 basis. The Company anticipates the split will be effective on April 8, 2015. At the opening of trading on that day, Positron's common stock will begin trading on a 1:400 reverse split-adjusted basis. Intra-Cellular Therapies Presents the ITI-007 Clinical Development Program at the 15th International Congress on Schizophrenia Research
GlobeNewswire - Tue Mar 31, 7:00AM CDT
Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, presented data regarding the ITI-007 development program and described the rationale supporting the strategy for the advancement of ITI-007 in multiple clinical indications at the 15th International Congress on Schizophrenia Research (ICOSR) in Colorado Springs.
ITCI: 37.43 (-1.78)
MediPoint: Nuclear Imaging - EU Analysis and Market Forecasts
PR Newswire - Mon Mar 23, 3:16PM CDT
Summary
MediPoint: Nuclear Imaging - South America Analysis and Market Forecasts
PR Newswire - Mon Mar 23, 3:06PM CDT
Summary
MediPoint: Nuclear Imaging - APAC Analysis and Market Forecasts
PR Newswire - Mon Mar 23, 2:50PM CDT
Summary
Leading 100 medical technology companies of USA/Canada 2015
M2 - Mon Mar 23, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7pc3fm/usacanada) has announced the addition of the "USA/Canada Medical Technology 100: An Industry Report" report to their offering. Medical technology aims to improve the quality of healthcare provided. Recent advances in this industry globally are focusing on cost reduction, less-invasive treatment options, and reduction in hospital stays and rehabilitation process. Health care technology assessment is a thriving industry in the United States, used by government, insurers, medical societies, hospitals, and other groups for their own purposes. Most of the top medical technology companies come from the United States. In general, trends show an increasing use of medical technology products with demand expected to grow some four percent in the United States. In Canada too, the medical device advancements help save the lives of patients by improving the accuracy of diagnoses, enhancing treatments and cure of diseases, reducing long-term disabilities and helping to provide better medical care. Covering a wide range of products, medical technology examples include pacemakers, artificial heart valves, hip implants, synthetic skin, scalpels, and medical laboratory diagnostic instruments. With this special industry report, our endeavor is to provide the new investors with a complete resourceful research report for familiarizing with the present investment trends in the USA/Canadian medical technology industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical technology companies of USA/Canada - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances with foreign companies - International presence of USA/Canadian medical technology companies - R&D activities in the industry Report Includes Companies Engaged in: - Manufacturing research instruments and scientific analytical equipment - Providing software for improving treatments - Providing medical information technology - Manufacturing medical bio-tech products - Providing value-based healthcare services - Manufacturing molecular diagnostic instruments - Manufacturing pacemakers, imaging instruments, dialysis machines and implants, hip and knee replacement medical devices, heart stents, thermal cyclers and mass spectrometers, microarrays and other similar products Key Topics Covered: Introduction Analysis Section 1. Rankings of Medical Technology Companies of USA/Canada 1.1. Leading 100 Medical Technology Companies of USA/Canada (based on recent sales, net income, total assets, total equity) 1.2. Most Growing 25 Medical Technology Companies of USA/Canada 1.3. Most Profitable 25 Medical Technology Companies of USA/Canada 2. Stock Market Performance over 5 Years. Leading 25 Medical Technology Companies of USA/Canada News Section 3. Key News of Medical Technology Sector in USA/Canada for Year 2014 3.1 - Key Company News. By Country and Company 3.2 - Key Company News. By News Category 3.3 - Key Industry News. By News Category 4. International Alliances of Medical Technology Companies in USA/Canada 5. International Presence of USA/Canadian Medical Technology Companies 6. Research and Development Activities in USA/Canadian Medical Technology Industry 7. Mergers and Acquisitions in USA/Canadian Medical Technology Industry Companies Mentioned (Partial List) - LED Medical Diagnostics Incorporated (Canada) - Masimo Corporation (United States) - Mazor Robotics Ltd (United States) - Medtronic, Incorporated (United States) - Mela Sciences Incorporation (United States) - Novation Holdings, Inc. (United States) - Oncologix Tech, Inc. (United States) - Pathfinder Cell Therapy Inc (United States) - Positron Corporation (United States) - Revolutions Medical Corporation (United States) - Rockwell Medical Incorporated (United States) - SQI Diagnostics Inc. (Canada) - The Cooper Companies, Inc. (United States) - Titan Medical Inc. (Canada) For more information visit http://www.researchandmarkets.com/research/7pc3fm/usacanada
MASI: 50.50 (-1.02), MDT: 84.14 (-0.45), MZOR: 16.03 (+0.17)
Research and Markets: MediPoint: Nuclear Imaging - APAC Analysis and Market Forecasts to 2020
BusinessWire - Mon Mar 23, 7:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mxck48/medipoint) has announced the addition of the "MediPoint: Nuclear Imaging - APAC Analysis and Market Forecasts" report to their offering.
MediPoint: Nuclear Imaging - APAC Analysis and Market Forecasts to 2020
M2 - Mon Mar 23, 6:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cf2bnd/medipoint) has announced the addition of the "MediPoint: Nuclear Imaging - APAC Analysis and Market Forecasts" report to their offering. This report examines how new technologies can emerge in the face of economic pressures that may affect the demand for nuclear imaging, and how healthcare reforms are impacting nuclear medicine. The advent of hybrid imaging has enabled PET/CT imaging to undergo explosive growth. However, this has been at the cost of an increased demand on struggling healthcare budgets. PET and SPECT imaging are well established techniques within nuclear imaging, and are the main focus of this report PET imaging uses Positron Emitting radioactive tracers with a short half life, to image metabolically active organs PET combined with CT allows precise anatomical imaging of the body, identifying diseased areas depending upon the tracer used PET/CT is most often used for cancer diagnosis PET/MRI is a new technique that was introduced to reduce patient exposure to radiation PET only systems are now generally considered obsolete, due to the superior imaging quality of PET/CT Scope - An overview of Nuclear Imaging, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized APAC Nuclear Imaging market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Nuclear Imaging - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Nuclear Imaging sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers and Barriers 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlooks 12 Appendix Companies Mentioned - DDD-Diagnostic - Digirad - GE Healthcare - GVI Medical Devices - Mediso Medical Imaging Systems - NeuroLogica - Neusoft Medical Systems - NuCare Medical Systems - Oncovision - Philips Healthcare - Shimadzu - Siemens Healthcare - SurgicEye - Toshiba Medical For more information visit http://www.researchandmarkets.com/research/cf2bnd/medipoint
MDSY: 1.50 (-0.01)
MediPoint: Nuclear Imaging - EU Analysis and Market Forecasts 2014-2020
M2 - Mon Mar 23, 6:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2n27tb/medipoint) has announced the addition of the "MediPoint: Nuclear Imaging - EU Analysis and Market Forecasts" report to their offering. This report examines how new technologies can emerge in the face of economic pressures that may affect the demand for nuclear imaging, and how healthcare reforms are impacting nuclear medicine. The advent of hybrid imaging has enabled PET/CT imaging to undergo explosive growth. However, this has been at the cost of an increased demand on struggling healthcare budgets. PET and SPECT imaging are well established techniques within nuclear imaging, and are the main focus of this report PET imaging uses Positron Emitting radioactive tracers with a short half life, to image metabolically active organs PET combined with CT allows precise anatomical imaging of the body, identifying diseased areas depending upon the tracer used PET/CT is most often used for cancer diagnosis PET/MRI is a new technique that was introduced to reduce patient exposure to radiation PET only systems are now generally considered obsolete, due to the superior imaging quality of PET/CT An early diagnosis of disease is the foundation of increasing survival rates. Single-photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging are diagnostic imaging techniques that are widely used in a variety of disease areas including oncology, cardiovascular disease, bone disease, and infectious disease. This report provides an analysis of the nuclear imaging market, with a particular focus on SPECT and PET imaging and hybrid modalities within the 5EU (France, Germany, Italy, Spain, and UK). Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 3.1 Nuclear Imaging Techniques 3.2 Clinical Applications of Nuclear Imaging Technology 3.3 Advantages and Disadvantages of Nuclear Imaging Technologies 3.4 Market Access 3.5 Reimbursement 3.6 Procedure Trends 3.7 Regulatory Issues/Recalls 3.8 M&As and Key Partnerships 3.9 Economic Impact 4 Unmet Needs 4.1 Overview 4.2 Improved Reimbursement for New Techniques 4.3 Lack of Binding Clinical Guidelines 4.4 Patient Comfort and Convenience 4.5 Reducing Radiation Exposure 4.6 Improved Scanner Performance 4.7 Image Processing Software Improvements 4.8 Increased Risk of Artifacts in Hybrid Images 4.9 Demand for New Radiotracers 4.10 Improved Clinical Input into the Design Process 5 Market Opportunity Analysis 5.1 Cheaper, Simpler Nuclear Imaging Devices 5.2 SPECT/CT in Developing Countries 5.3 Increased Demand for Teleradiology Services 6 Market Drivers and Barriers 7 Competitive Assessment 7.1 Overview 7.2 Dedicated PET Systems 7.3 PET/CT Systems 7.4 PET/MRI Systems 7.5 Dedicated SPECT Systems 7.6 SPECT/CT Systems 7.7 PET/Ultrasound and SPECT/Ultrasound Systems 8 Pipeline Assessment 8.1 Overview 8.2 Pipeline by Phases in Development 8.3 Product Profiles 8.3.1 Brain Biosciences CerePET 8.3.2 ECORAD Dual Modality Imager 8.3.3 FMI Technologies ScintiStar PET/CT 8.3.4 IntraMedical Imaging Marginator Beta Camera 8.3.5 INSERT SPECT/MRI 8.3.6 Nucare/Zecotek Photonics New Generation PET Scanning Device 8.3.7 Philips Healthcare PET Alpha Ring Detector 8.3.8 Photo Diagnostic Systems NeuroPET/CT 8.3.9 SynchroPET Breast PET/MRI 8.3.10 SynchroPET Wrist Scanner 8.3.11 SurgicEye SPECT Hybrid 9 Clinical Trials to Watch 10 Current and Future Players 10.1 Overview 10.2 Trends in Corporate Strategy 10.3 Company Profiles 10.3.1 DDD-Diagnostic 10.3.2 Digirad 10.3.3 GE Healthcare 10.3.4 GVI Medical Devices 10.3.5 Mediso Medical Imaging Systems 10.3.6 NeuroLogica 10.3.7 Neusoft Medical Systems 10.3.8 NuCare Medical Systems 10.3.9 Oncovision 10.3.10 Philips Healthcare 10.3.11 Shimadzu 10.3.12 Siemens Healthcare 10.3.13 SurgicEye 10.3.14 Toshiba Medical 10.3.15 Other Companies 11 Market Outlooks 12 Appendix For more information visit http://www.researchandmarkets.com/research/2n27tb/medipoint
MDSY: 1.50 (-0.01)
Positron Access Names Alan Pritchard Senior Vice President of Sales
PRWeb - Thu Feb 19, 5:07AM CST
Positron Access Solutions, the leader in high bandwidth Ethernet over copper pairs solutions, is pleased to announce the appointment of Alan Pritchard as Senior Vice President of Sales. Pritchard, a veteran in the telecom industry, will lead the sales growth of Positron's FlexStream bonded-copper and fiber solutions, which deliver 100 Mbps to Gigabit Ethernet services over copper and fiber infrastructure. Pritchard brings with him a wealth of experience and accomplishments in Carrier sales and business development. Previously he was VP of Sales at Coriant/Tellabs, SVP Business Development at Amerlink, and obtained extensive experience at Nortel including Global VP of Carrier Solutions.
Global Preclinical Imaging Market 2015-2019 with Aspect Imaging, Bioscan, Bruker, Mediso Medical Imaging Systems, PerkinElmer, Siemens Healthcare & Thermo Fisher Scientific Dominating
M2 - Sat Jan 31, 12:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/m5vndn/global) has announced the addition of the "Global Preclinical Imaging Market 2015-2019" report to their offering. The Global Pre-clinical Imaging market to grow at a CAGR of 15.02% over the period 2014-2019. Pre-clinical Imaging is in vivo imaging of small animals, which had been progressively deployed in drug development process. It helps in the visualizing and monitoring of animals for research with respect to tissue, organ, cell (at molecular level), and physiological and environmental changes. One of the main application areas of pre-clinical imaging is early detection of diseases. Currently the most used imaging modalities are optical (fluorescence and bioluminescence), PET, and MRI. In addition, multi-modalities such as PET CT and SPECT CT are the most used imaging combinations. In vivo imaging is increasingly used in target identification, compound optimisation and pre-Phase I studies, and in the drug development process. Thus, it bridges the gap between in vitro exploratory and in vivo clinical research. The use of multi-modalities imaging systems is a major trend in the market. Also, innovation and advances in technologies to meet research needs, safety, efficacy, and potential reversibility have resulted in the involvement of multi-modalities imaging systems. According to the report, an increase in R&D in pharma companies is one of the major drivers of the market. Because of the intense competition in the market, vendors try to develop new drugs and spend huge amounts toward drug development. Further, the report states that high cost is a major challenge that the market faces. The cost required to complete preclinical studies depends on the research involved. Vendors spend huge amounts on R&D, which will have a significant effect on the company's economy. Pre-clinical imaging systems can be segmented based on the type of equipment, as mentioned below: - Micro MRI - Micro-PET - Micro-CT - PAT - SPECT - Multi-modality - Optical Imaging - Ultrasound Key Vendors - Aspect Imaging - Bioscan (Subsidiary of Trifoil Imaging) - Bruker Corporation - Mediso Medical Imaging Systems - PerkinElmer - Siemens Healthcare - Thermo Fisher Scientific Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Type of Modality - Global Single Modality Imaging Technique Market - Global Multi-modality Imaging Technique Market - Market Segmentation by Sub-classification - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis Companies Mentioned - Aspect Imaging - Bioscan (Subsidiary of Trifoil Imaging) - Bruker Corporation - Mediso Medical Imaging Systems - PerkinElmer - Siemens Healthcare - Thermo Fisher Scientific - Agilent Technologies - Capintec - Hitachi Medical - LI-COR Biosciences - Miltenyi Biotec GMBH - Naviscan - Positron - Promega - Quintiles For more information visit http://www.researchandmarkets.com/research/m5vndn/global
A: 45.36 (-0.01), PKI: 52.35 (-0.38)
Institute for Nuclear Research of the Russian Academy of Sciences Granted U.S. Patent for Radiostrontium Production Technology Included in Licensing Agreement with Positron Corporation
PR Newswire - Tue Jan 20, 10:04AM CST
Positron Corporation (OTCBB: POSC) is pleased to announce that the United States Patent and Trademark Office (USPTO) has awarded the Institute for Nuclear Research (INR) of the Russian Academy of Sciences a patent (U.S. No. 8,929,503) for the method for producing strontium-82 (Sr-82) - a precursor to rubidium-82 (Rb-82), the leading radiopharmaceutical used in Positron Emission Tomography (PET) myocardial perfusion imaging. It is the second patent for this technology in North America included in a license agreement between INR and Positron Corporation: INR has been awarded a Canadian patent (CA 2719347) for the same technology in July 2014. The rights to this patented technology have been granted by INR to Positron Corporation. Although other licensees, from France and Russia, can sell Sr-82 produced with the patented technology, only Positron Corporation has the right to utilize the technology in North America.
Breast Imaging Technologies Market (Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound) will reach $3 Billion by 2019
M2 - Mon Dec 29, 6:01AM CST
This report studies the global Breast Imaging Technologies Market over the forecast period from 2014 to 2019. The market is expected to reach ~$3 billion by 2019, at CAGR of 8.1% from 2014 to 2019.
Breast Imaging Technologies Market will reach $3 Billion by 2019
M2 - Fri Nov 28, 5:52AM CST
The report "Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging, Whole Breast Ultrasound, Breast Thermography) - Global Forecasts to 2019" analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).
Global ESL Market 2015-2019: Key Vendors are Altiere, Displaydata, Pricer, Store Electronic Systems and Teraoka Seiko
M2 - Tue Nov 25, 4:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/9k2slf/global_esl_market) has announced the addition of the "Global ESL Market 2015-2019" report to their offering. Increased inclinations towards dynamic pricing are one of the emerging trends in this market. Retailers use various price optimization and revenue management techniques to exceed sales and increase profits. They use dynamic pricing and change product prices based on certain marketing strategies and market demand for products. According to the report, one of the major driving forces behind the success of ESLs is the return on investment they offer to retailers. It is estimated that retailers will get their full return on the investment they make on ESLs within 18 to 24 months from the implementation of these labels. Further, the report states that ESL vendors are witnessing a decline in their profit margins owing to the rise in prices of raw materials and increased competition among vendors. The new vendors are focused more on end-user requirements and are developing ESL solutions based on these requirements, which makes them a preferred choice for global vendors. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Global ESL Market Penetration 08. Market Segmentation by Retail Store Type 09. Market Segmentation by Wireless Solution 10. Market Segmentation by Distribution Channel 11. Geographical Segmentation 12. Impact of New Technologies in Retail 13. Buying Criteria 14. Market Growth Drivers 15. Drivers and their Impact 16. Market Challenges 17. Impact of Drivers and Challenges 18. Market Trends 19. Trends and their Impact 20. Vendor Landscape 21. Key Vendor Analysis 22. Other Reports in this Series Companies Mentioned: - Advantech US - Altiere - CEST - Displaydata - E Ink - ELTRADE - Herbert Retail - ILID - LG Innotek - Mirador Marketing - NZ Electronic Shelf Labelling - Opticon - Positron - PriceWizard - Pricer - Samsung ElectroMechanics - Store Electronic Systems - Tagnetics - Teraoka Seiko - Toshiba Global Commerce Solutions - UNO ESL - Wincor Nixdorf - Wuxi Wei Feng Technology - imagotag For more information visit http://www.researchandmarkets.com/research/9k...esl_market
Breast Imaging Technologies Market (Analog Mammography, Digital Mammography, Tomosynthesis, Positron Emission Mammography, PET/CT, MBI, Breast MRI, Ultrasound, Optical Imaging...) - Global Forecasts to 2019
PR Newswire - Wed Oct 29, 4:00PM CDT
The global breast imaging technologies market is estimated to grow at a CAGR of 8.1% from 2014 to 2019. Although the mature markets (such as the U.S., Germany, and the U.K.) hold larger shares in the breast imaging technologies market, the Asia-Pacific region is expected to grow at the highest CAGR of 10.2% in the forecast period. The growth of the breast imaging technologies market is driven by factors such as public and private initiatives to increase awareness about early breast cancer screening, technological developments, growing demand for the use of minimal or negligible doses of radiation, and increasingly aging population. However, factors such as side effects of radiation exposure and high installation cost of breast imaging systems are restraining the growth of this market. Moreover, emerging economies such as India and China are creating growth opportunities for the breast imaging technologies market in these regions.
SOFIE BIOSCIENCES receives $1.5M NCI Phase II SBIR
PR Newswire - Thu Oct 16, 8:03AM CDT
SOFIE BIOSCIENCES, a leader in the field of Positron Emission Tomography (PET) imaging, including probes, scanners, and chemistry systems, announced today that the National Cancer Institute (NCI) has awarded the company a Phase II Small Business Innovation Research (SBIR) contract for approximately $1.5M over two years. This contract will support the further development of SOFIE's family of proprietary imaging probes, known as [18F]FAC, that measure the enzyme, dCK, which controls the rate of DNA production through the salvage pathway. Cancer drugs, like gemcitabine and others, use dCK to convert the drug into a pharmacologically active product that blocks the high rates of DNA replication for growth of malignant cells. One of SOFIE's objectives with [18F]FAC is to use PET imaging to allow physicians to search throughout the body for tumors that will respond to drugs that target dCK, thus enabling more patient-specific treatment selection.
Global Breast Imaging Technologies Market to 2019
M2 - Thu Oct 16, 3:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jns6bn/breast_imaging) has announced the addition of the "Breast Imaging Technologies Market - Global Forecasts to 2019" report to their offering. The global breast imaging market holds a significant share of the medical device industry owing to rising awareness about the early screening of breast cancer. Though digital Mammography is the gold standard in the current breast imaging market, modalities such as breast MRI Scans, breast ultrasound and CTs are expected to drastically improve the breast Imaging Market scenario. This research analysis provides, a detailed information on breast imaging technological advancements in breast cancer diagnosis. This research report identifies and evaluates key advancements of breast screening modalities in development and approval stages. Patent analysis, investor analysis and investment opportunity evaluation along with multi-level criteria technology benchmarking are assessed within the breast imaging sector. Strategic recommendations for technology stakeholders are elaborately discussed in this research service. The global breast imaging market is estimated to grow at a CAGR of 8.1% in the forecast period. Global rise in the incidences and prevalence of breast cancer cases, rapid growth in aging population, development of advanced breast imaging technologies, and increasing awareness about early breast cancer screening are some of the key factors that are fueling the growth of the market. However, side effects of radiation dosage during breast imaging procedures, high installation cost of this systems, and false cancer diagnosis are some of the key factors hampering the growth of this market. Furthermore, stringent regulatory approvals for new technologies and government pressure to reduce the usage of radiation dose are some of the key challenges faced by market players. The emerging markets including China and India have become attractive for companies engaged in the development and marketing of the breast imaging technologies. Rising breast cancer awareness, government initiatives to increasing awareness about women healthcare, rising incidences of breast cancer, and increasing government investments in this technologies are the key factors propelling the demand of the this technologies in the emerging markets. In 2013, Hologic, Inc. (U.S.) held the leading position in the global mammography market. Over the past three years, the company adopted expansion of its R&D capabilities, new product launches, and strategic partnerships/agreements as its key business strategies to ensure its dominant position in this market. In addition, GE Healthcare (U.K.), Philips Healthcare (Netherlands), Siemens Healthcare (Germany), SonoCine, Inc. (U.S.), and Toshiba Corporation (Japan) are some other key players in the global mammography market. Scope of the Report By Type - Ionizing Breast Imaging Technologies - Analog Mammography - Full-Field Digital Mammography - 3D Breast Tomosynthesis - Positron Emission Tomography/Computed Tomography (PET/CT) - Molecular Breast Imaging (MBI) - Cone Beam Computed Tomography (CBCT) - Positron Emission Mammography (PEM) - Non-ionizing Breast Imaging Technologies - Breast MRI - Breast Ultrasound - Optical Imaging - Whole Breast Ultrasound - Breast Thermography Companies Mentioned - Aurora Imaging Technology, Inc. - Dilon Technologies, Inc. - Dune Medical Devices - Gamma Medica, Inc. - Ge Healthcare (Apart of General Electric Company) - Hologic, Inc. - Philips Healthcare (A Part of Konninklijke Philips N.V.) - Siemens Healthcare (A Part of Siemens AG) - Sonocine, Inc. - Toshiba Corporation For more information visit http://www.researchandmarkets.com/research/jn...st_imaging
GE: 30.60 (-0.04), HOLX: 33.81 (+0.11)
(0)
(0)Scroll down for more posts ▼